Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program – Contributions to Firms

ME Therapeutics Inc.

$50,000.00

Development of a Novel Immuno Oncology Prodrug for the Treatment of Cancer

FY 2023-24 · 2023-09-11

Summary
The project involve efficacy evaluation of the novel pro-drug candidate formulations in various cancer models.
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
837332592
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2024-03-31
Agreement Number
1010857
Agreement Start Date
2023-09-11
Agreement Title
Development of a Novel Immuno Oncology Prodrug for the Treatment of Cancer
Agreement Title (French)
Développement d’un nouveau promédicament immuno-oncologique pour le traitement du cancer
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project involve efficacy evaluation of the novel pro-drug candidate formulations in various cancer models.
Description (French)
Le projet comprend l’évaluation de l’efficacité des nouvelles formulations de promédicaments candidats dans divers modèles de cancer.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
837332592
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
ME Therapeutics Inc.
Recipient Postal Code
V6B 0N3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2023-2024-Q3-1010857
ME Therapeutics Inc. - $50,000 Contribution (2023-24) | Canada Spends